HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Friday, 6 January 2012

Recently published CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  11 papers were listed this time. Here's a handful in our areas of research interest:

Montero AJ, Avancha K, Glück S, et al. A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer. Breast Cancer Res Treat. 2011 Dec 27. [Epub ahead of print] PubMed PMID: 22200867.

Anokye NK, Trueman P, Green C, Pavey TG, Hillsdon M, Taylor RS. The cost-effectiveness of exercise referral schemes. BMC Public Health. 2011 Dec 26;11(1):954. [Epub ahead of print] PubMed PMID: 22200193.

van Gils PF, Over EA, Hamberg-van Reenen HH, et al. The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population. BMJ Open. 2011 Dec 21;1(2):e000363. Print 2011. PubMed PMID: 22189351.